SCM
WST icon

SevenOneSeven Capital Management’s West Pharmaceutical WST Stock Holding History

SevenOneSeven Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-805
Closed -$272K – 54
2023
Q3 		$272K Buy
805
+25
+3% +$9.67K 0.63% 38
2023
Q2 		$308K Sell
780
-2
-0.3% -$714 0.69% 29
2023
Q1 		$282K Sell
782
-358
-31% -$105K 0.63% 26
2022
Q4 		$268K Buy
1,140
+105
+10% +$24.9K 0.58% 46
2022
Q3 		$255K Buy
1,035
+29
+3% +$8.84K 0.6% 39
2022
Q2 		$304K Buy
1,006
+21
+2% +$6.83K 0.71% 34
2022
Q1 		$405K Buy
985
+1
+0.1% +$391 0.84% 33
2021
Q4 		$462K Buy
984
+120
+14% +$51.7K 0.91% 29
2021
Q3 		$367K Buy
864
+14
+2% +$5.9K 0.93% 28
2021
Q2 		$305K Buy
850
+95
+13% +$31.4K 0.79% 37
2021
Q1 		$213K Buy
+755
New +$216K 0.78% 42

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SevenOneSeven Capital Management's WST Position: Q4 2023 in Review

SevenOneSeven Capital Management sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 805 shares — an estimated $272K sold.

SevenOneSeven Capital Management first reported a position in WST in Q1 2021 and held it in 11 quarters. The position peaked at $462K in Q4 2021. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • SevenOneSeven Capital Management reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • SevenOneSeven Capital Management sold 805 West Pharmaceutical shares in Q4 2023, an estimated $272K.
  • SevenOneSeven Capital Management first reported a position in West Pharmaceutical in Q1 2021 and held it in 11 quarters.
  • SevenOneSeven Capital Management's West Pharmaceutical position peaked at $462K in Q4 2021.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on SevenOneSeven Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.